PETS
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Trades at a low multiple of sales, but earnings are non-existent.
- Low P/S ratio (0.27)
- Low P/B ratio (1.53)
- Negative Forward P/E
- No Graham Number due to negative earnings
Growth metrics are in a state of freefall.
- YoY Revenue Growth -21.70%
- Q/Q Revenue Growth -29.95%
- YoY EPS Growth -1566.7%
Long-term historical performance is overwhelmingly negative.
- 5Y Change -91.2%
- 3Y Change -84.4%
- Consistent failure to meet analyst estimates
Low debt is the only saving grace, but liquidity is tightening.
- Low Debt/Equity (0.02)
- Piotroski F-Score 5/9
- Current Ratio < 1.0
- Quick Ratio 0.52
Non-dividend paying stock.
- No dividend paid
- No history of payouts
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for PETS and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
PETS
PetMed Express, Inc.
Primary
|
-91.2% | -84.4% | -23.0% | -7.9% | -8.2% | +1.3% |
|
HYFT
MindWalk Holdings Corp.
Peer
|
-91.3% | -62.5% | +166.8% | -40.9% | -16.4% | -6.1% |
|
NTRB
Nutriband Inc.
Peer
|
-28.9% | +17.2% | -16.9% | -45.8% | +7.4% | +4.1% |
|
POCI
Precision Optics Corporation, Inc.
Peer
|
-7.8% | -29.0% | +17.5% | +13.0% | +13.2% | +17.8% |
|
ELUT
Elutia Inc.
Peer
|
-91.4% | -20.8% | -53.7% | +28.2% | -2.6% | +4.6% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
PETS
PetMed Express, Inc.
|
BEARISH | $50.08M | - | -100.6% | -34.7% | $2.34 | |
|
HYFT
MindWalk Holdings Corp.
|
BEARISH | $49.98M | - | -58.8% | -43.6% | $1.07 | Compare |
|
NTRB
Nutriband Inc.
|
BEARISH | $49.67M | - | -136.1% | -% | $4.08 | Compare |
|
POCI
Precision Optics Corporation, Inc.
|
BEARISH | $51.36M | - | -73.6% | -28.3% | $4.7 | Compare |
|
ELUT
Elutia Inc.
|
BULLISH | $48.77M | - | -% | 434.2% | $1.14 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-30 | MENNEN JUSTIN L. | Director | Stock Award | 33,846 | - |
| 2025-10-30 | LACAMP JAMES | Director | Stock Award | 34,866 | - |
| 2025-10-30 | SOLIVAN LEAH A. | Director | Stock Award | 33,846 | - |
| 2025-10-30 | BATUSHANSKY PETER | Director | Stock Award | 33,846 | - |
| 2025-10-30 | KRULIK DOUGLAS | Chief Financial Officer | Stock Award | 20,000 | - |
| 2025-10-30 | FULGONI GIAN M | Director | Stock Award | 33,846 | - |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
PETS's 10-Q filing dated February 5, 2026, does not provide specific financial highlights in the provided excerpt. However, the company identifies a key risk regarding unsolicited acquisition proposals and proxy contests, which could result in substantial costs, business disruption, and stock price volatility.
The provided filing for PETS does not include specific financial highlights but emphasizes risks related to unsolicited acquisition proposals and proxy contests. Such activities could result in substantial costs, divert management's attention, and cause significant fluctuations in the company's stock price.
The provided filing for PETS does not include specific financial highlights but emphasizes risks related to unsolicited acquisition proposals and proxy contests. Such activities could result in substantial costs, divert management's attention, and cause significant fluctuations in the company's stock price.
Past News Coverage
Recent headlines mentioning PETS from our newsroom.